ID   NPAS2_HUMAN             Reviewed;         824 AA.
AC   Q99743; Q4ZFV9; Q53SQ3; Q86V96; Q99629;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Neuronal PAS domain-containing protein 2;
DE            Short=Neuronal PAS2;
DE   AltName: Full=Basic-helix-loop-helix-PAS protein MOP4;
DE   AltName: Full=Class E basic helix-loop-helix protein 9;
DE            Short=bHLHe9;
DE   AltName: Full=Member of PAS protein 4;
DE   AltName: Full=PAS domain-containing protein 4;
GN   Name=NPAS2; Synonyms=BHLHE9, MOP4, PASD4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-394 AND LEU-471.
RX   PubMed=9012850; DOI=10.1073/pnas.94.2.713;
RA   Zhou Y.-D., Barnard M., Tian H., Li X., Ring H.Z., Francke U.,
RA   Shelton J., Richardson J., Russell D.W., McKnight S.L.;
RT   "Molecular characterization of two mammalian bHLH-PAS domain proteins
RT   selectively expressed in the central nervous system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:713-718(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-394.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-626, AND VARIANT ALA-394.
RX   PubMed=9079689; DOI=10.1074/jbc.272.13.8581;
RA   Hogenesch J.B., Chan W.K., Jackiw V.H., Brown R.C., Gu Y.-Z.,
RA   Pray-Grant M., Perdew G.H., Bradfield C.A.;
RT   "Characterization of a subset of the basic-helix-loop-helix-PAS
RT   superfamily that interacts with components of the dioxin signaling
RT   pathway.";
RL   J. Biol. Chem. 272:8581-8593(1997).
RN   [5]
RP   FUNCTION.
RX   PubMed=11441147; DOI=10.1126/science.1060699;
RA   Reick M., Garcia J.A., Dudley C., McKnight S.L.;
RT   "NPAS2: an analog of clock operative in the mammalian forebrain.";
RL   Science 293:506-509(2001).
RN   [6]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=11441146; DOI=10.1126/science.1060698;
RA   Rutter J., Reick M., Wu L.C., McKnight S.L.;
RT   "Regulation of clock and NPAS2 DNA binding by the redox state of NAD
RT   cofactors.";
RL   Science 293:510-514(2001).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NCOA3; KAT2B;
RP   CREBBP AND EP300.
RX   PubMed=14645221; DOI=10.1074/jbc.M311973200;
RA   Curtis A.M., Seo S.B., Westgate E.J., Rudic R.D., Smyth E.M.,
RA   Chakravarti D., FitzGerald G.A., McNamara P.;
RT   "Histone acetyltransferase-dependent chromatin remodeling and the
RT   vascular clock.";
RL   J. Biol. Chem. 279:7091-7097(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=18439826; DOI=10.1016/j.cub.2008.04.012;
RA   Hampp G., Ripperger J.A., Houben T., Schmutz I., Blex C.,
RA   Perreau-Lenz S., Brunk I., Spanagel R., Ahnert-Hilger G., Meijer J.H.,
RA   Albrecht U.;
RT   "Regulation of monoamine oxidase A by circadian-clock components
RT   implies clock influence on mood.";
RL   Curr. Biol. 18:678-683(2008).
RN   [9]
RP   FUNCTION.
RX   PubMed=18819933; DOI=10.1158/1541-7786.MCR-07-2094;
RA   Hoffman A.E., Zheng T., Ba Y., Zhu Y.;
RT   "The circadian gene NPAS2, a putative tumor suppressor, is involved in
RT   DNA damage response.";
RL   Mol. Cancer Res. 6:1461-1468(2008).
RN   [10]
RP   REVIEW.
RX   PubMed=23303907; DOI=10.1152/physrev.00016.2012;
RA   Eckel-Mahan K., Sassone-Corsi P.;
RT   "Metabolism and the circadian clock converge.";
RL   Physiol. Rev. 93:107-135(2013).
RN   [11]
RP   ASSOCIATION OF VARIANT LEU-471 WITH SAD.
RX   PubMed=12655319; DOI=10.1038/sj.npp.1300121;
RA   Johansson C., Willeit M., Smedh C., Ekholm J., Paunio T., Kieseppa T.,
RA   Lichtermann D., Praschak-Rieder N., Neumeister A., Nilsson L.G.,
RA   Kasper S., Peltonen L., Adolfsson R., Schalling M., Partonen T.;
RT   "Circadian clock-related polymorphisms in seasonal affective disorder
RT   and their relevance to diurnal preference.";
RL   Neuropsychopharmacology 28:734-739(2003).
RN   [12]
RP   VARIANT ALA-394.
RX   PubMed=17096334; DOI=10.1002/ijc.22321;
RA   Zhu Y., Leaderer D., Guss C., Brown H.N., Zhang Y., Boyle P.,
RA   Stevens R.G., Hoffman A., Qin Q., Han X., Zheng T.;
RT   "Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier
RT   for the risk of non-Hodgkin's lymphoma.";
RL   Int. J. Cancer 120:432-435(2007).
RN   [13]
RP   VARIANT ALA-394.
RX   PubMed=17453337; DOI=10.1007/s10549-007-9565-0;
RA   Zhu Y., Stevens R.G., Leaderer D., Hoffman A., Holford T., Zhang Y.,
RA   Brown H.N., Zheng T.;
RT   "Non-synonymous polymorphisms in the circadian gene NPAS2 and breast
RT   cancer risk.";
RL   Breast Cancer Res. Treat. 107:421-425(2008).
CC   -!- FUNCTION: Transcriptional activator which forms a core component
CC       of the circadian clock. The circadian clock, an internal time-
CC       keeping system, regulates various physiological processes through
CC       the generation of approximately 24 hour circadian rhythms in gene
CC       expression, which are translated into rhythms in metabolism and
CC       behavior. It is derived from the Latin roots 'circa' (about) and
CC       'diem' (day) and acts as an important regulator of a wide array of
CC       physiological functions including metabolism, sleep, body
CC       temperature, blood pressure, endocrine, immune, cardiovascular,
CC       and renal function. Consists of two major components: the central
CC       clock, residing in the suprachiasmatic nucleus (SCN) of the brain,
CC       and the peripheral clocks that are present in nearly every tissue
CC       and organ system. Both the central and peripheral clocks can be
CC       reset by environmental cues, also known as Zeitgebers (German for
CC       'timegivers'). The predominant Zeitgeber for the central clock is
CC       light, which is sensed by retina and signals directly to the SCN.
CC       The central clock entrains the peripheral clocks through neuronal
CC       and hormonal signals, body temperature and feeding-related cues,
CC       aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression
CC       to create a peak of protein expression once every 24 hours to
CC       control when a particular physiological process is most active
CC       with respect to the solar day. Transcription and translation of
CC       core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2,
CC       PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm
CC       generation, whereas delays imposed by post-translational
CC       modifications (PTMs) are important for determining the period
CC       (tau) of the rhythms (tau refers to the period of a rhythm and is
CC       the length, in time, of one complete cycle). A diurnal rhythm is
CC       synchronized with the day/night cycle, while the ultradian and
CC       infradian rhythms have a period shorter and longer than 24 hours,
CC       respectively. Disruptions in the circadian rhythms contribute to
CC       the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop
CC       (TTFL) forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or
CC       ARNTL2/BMAL2, form the positive limb of the feedback loop, act in
CC       the form of a heterodimer and activate the transcription of core
CC       clock genes and clock-controlled genes (involved in key metabolic
CC       processes), harboring E-box elements (5'-CACGTG-3') within their
CC       promoters. The core clock genes: PER1/2/3 and CRY1/2 which are
CC       transcriptional repressors form the negative limb of the feedback
CC       loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2
CC       heterodimer inhibiting its activity and thereby negatively
CC       regulating their own expression. This heterodimer also activates
CC       nuclear receptors NR1D1/2 and RORA/B/G, which form a second
CC       feedback loop and which activate and repress ARNTL/BMAL1
CC       transcription, respectively. The NPAS2-ARNTL/BMAL1 heterodimer
CC       positively regulates the expression of MAOA, F7 and LDHA and
CC       modulates the circadian rhythm of daytime contrast sensitivity by
CC       regulating the rhythmic expression of adenylate cyclase type 1
CC       (ADCY1) in the retina. NPAS2 plays an important role in sleep
CC       homeostasis and in maintaining circadian behaviors in normal
CC       light/dark and feeding conditions and in the effective
CC       synchronization of feeding behavior with scheduled food
CC       availability. Regulates the gene transcription of key metabolic
CC       pathways in the liver and is involved in DNA damage response by
CC       regulating several cell cycle and DNA repair genes.
CC       {ECO:0000269|PubMed:11441146, ECO:0000269|PubMed:11441147,
CC       ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:18439826,
CC       ECO:0000269|PubMed:18819933}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P97460};
CC   -!- ENZYME REGULATION: Carbon monoxide (CO) and the redox state of the
CC       cell can modulate the transcriptional activity of the NPAS2-
CC       ARNTL/BMAL1 heterodimer. NADH and NADPH enhance the DNA-binding
CC       activity of the heterodimer whereas CO binds the heme group in
CC       NPAS2 and inhibits the DNA-binding activity of the heterodimer.
CC       {ECO:0000250|UniProtKB:P97460}.
CC   -!- SUBUNIT: Component of the circadian clock oscillator which
CC       includes the CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or
CC       ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS and the PER proteins.
CC       Efficient DNA binding requires dimerization with another bHLH
CC       protein. Forms a heterodimer with ARNTL/BMAL1 and this
CC       heterodimerization is required for E-box-dependent
CC       transactivation. Interacts with NCOA3, KAT2B, CREBBP and EP300.
CC       {ECO:0000269|PubMed:14645221}.
CC   -!- INTERACTION:
CC       O00327-8:ARNTL; NbExp=4; IntAct=EBI-3932727, EBI-11991546;
CC       Q8WYA1-3:ARNTL2; NbExp=4; IntAct=EBI-3932727, EBI-12268276;
CC       O43639:NCK2; NbExp=4; IntAct=EBI-3932727, EBI-713635;
CC       Q96IV0:NGLY1; NbExp=4; IntAct=EBI-3932727, EBI-6165879;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00981, ECO:0000269|PubMed:14645221}.
CC   -!- POLYMORPHISM: Variants in NPAS2 show a susceptibility to seasonal
CC       affective disorder (SAD) [MIM:608516]. SAD is a depressive
CC       condition resulting from seasonal changes, and with diurnal
CC       preference. {ECO:0000269|PubMed:9012850}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77970; AAB47250.1; -; mRNA.
DR   EMBL; AC016738; AAY14822.1; -; Genomic_DNA.
DR   EMBL; AC092168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106891; AAX88966.1; -; Genomic_DNA.
DR   EMBL; BC051351; AAH51351.2; -; mRNA.
DR   EMBL; BC072383; AAH72383.1; -; mRNA.
DR   EMBL; U51625; AAC51211.1; -; mRNA.
DR   CCDS; CCDS2048.1; -.
DR   RefSeq; NP_002509.2; NM_002518.3.
DR   UniGene; Hs.156832; -.
DR   UniGene; Hs.705895; -.
DR   ProteinModelPortal; Q99743; -.
DR   SMR; Q99743; -.
DR   BioGrid; 110923; 26.
DR   DIP; DIP-60821N; -.
DR   IntAct; Q99743; 14.
DR   STRING; 9606.ENSP00000338283; -.
DR   iPTMnet; Q99743; -.
DR   PhosphoSitePlus; Q99743; -.
DR   BioMuta; NPAS2; -.
DR   DMDM; 311033423; -.
DR   PaxDb; Q99743; -.
DR   PeptideAtlas; Q99743; -.
DR   PRIDE; Q99743; -.
DR   Ensembl; ENST00000335681; ENSP00000338283; ENSG00000170485.
DR   GeneID; 4862; -.
DR   KEGG; hsa:4862; -.
DR   UCSC; uc002tap.2; human.
DR   CTD; 4862; -.
DR   DisGeNET; 4862; -.
DR   GeneCards; NPAS2; -.
DR   H-InvDB; HIX0200274; -.
DR   HGNC; HGNC:7895; NPAS2.
DR   HPA; HPA019674; -.
DR   MIM; 603347; gene.
DR   MIM; 608516; phenotype.
DR   neXtProt; NX_Q99743; -.
DR   OpenTargets; ENSG00000170485; -.
DR   PharmGKB; PA31696; -.
DR   eggNOG; ENOG410IQ5V; Eukaryota.
DR   eggNOG; ENOG410Y7Z8; LUCA.
DR   GeneTree; ENSGT00760000118788; -.
DR   HOVERGEN; HBG050997; -.
DR   InParanoid; Q99743; -.
DR   KO; K09026; -.
DR   OMA; SMFQTIK; -.
DR   OrthoDB; EOG091G11CV; -.
DR   PhylomeDB; Q99743; -.
DR   TreeFam; TF324568; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   ChiTaRS; NPAS2; human.
DR   GeneWiki; NPAS2; -.
DR   GenomeRNAi; 4862; -.
DR   PRO; PR:Q99743; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170485; -.
DR   CleanEx; HS_NPAS2; -.
DR   ExpressionAtlas; Q99743; baseline and differential.
DR   Genevisible; Q99743; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IPI:MGI.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; TAS:Reactome.
DR   GO; GO:0060548; P:negative regulation of cell death; IMP:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0051775; P:response to redox state; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00083; HLH; 1.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR001067; Nuc_translocat.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR013767; PAS_fold.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF00989; PAS; 1.
DR   PRINTS; PR00785; NCTRNSLOCATR.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00086; PAC; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   1: Evidence at protein level;
KW   Activator; Biological rhythms; Complete proteome; DNA damage;
KW   DNA-binding; Heme; Iron; Metal-binding; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    824       Neuronal PAS domain-containing protein 2.
FT                                /FTId=PRO_0000127406.
FT   DOMAIN        9     59       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   DOMAIN       82    152       PAS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      237    307       PAS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      311    354       PAC.
FT   REGION        1     61       Sufficient for heterodimer formation with
FT                                ARNTL/BMAL1, E-box binding and for the
FT                                effect of NADPH.
FT                                {ECO:0000250|UniProtKB:P97460}.
FT   METAL       119    119       Iron (heme B axial ligand).
FT                                {ECO:0000250|UniProtKB:P97460}.
FT   METAL       171    171       Iron (heme B axial ligand).
FT                                {ECO:0000250|UniProtKB:P97460}.
FT   VARIANT     394    394       T -> A (associated with non-Hodgkin's
FT                                lymphoma and breast cancer risk;
FT                                dbSNP:rs2305160).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17096334,
FT                                ECO:0000269|PubMed:17453337,
FT                                ECO:0000269|PubMed:9012850,
FT                                ECO:0000269|PubMed:9079689}.
FT                                /FTId=VAR_029078.
FT   VARIANT     471    471       S -> L (susceptibility to seasonal
FT                                affective disorder (SAD) and diurnal
FT                                preference; dbSNP:rs11541353).
FT                                {ECO:0000269|PubMed:9012850}.
FT                                /FTId=VAR_029079.
FT   CONFLICT     51     51       K -> E (in Ref. 4; AAC51211).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       S -> G (in Ref. 4; AAC51211).
FT                                {ECO:0000305}.
FT   CONFLICT    308    308       K -> T (in Ref. 1; AAB47250).
FT                                {ECO:0000305}.
SQ   SEQUENCE   824 AA;  91791 MW;  679919FCDD3AFDEB CRC64;
     MDEDEKDRAK RASRNKSEKK RRDQFNVLIK ELSSMLPGNT RKMDKTTVLE KVIGFLQKHN
     EVSAQTEICD IQQDWKPSFL SNEEFTQLML EALDGFIIAV TTDGSIIYVS DSITPLLGHL
     PSDVMDQNLL NFLPEQEHSE VYKILSSHML VTDSPSPEYL KSDSDLEFYC HLLRGSLNPK
     EFPTYEYIKF VGNFRSYNNV PSPSCNGFDN TLSRPCRVPL GKEVCFIATV RLATPQFLKE
     MCIVDEPLEE FTSRHSLEWK FLFLDHRAPP IIGYLPFEVL GTSGYDYYHI DDLELLARCH
     QHLMQFGKGK SCCYRFLTKG QQWIWLQTHY YITYHQWNSK PEFIVCTHSV VSYADVRVER
     RQELALEDPP SEALHSSALK DKGSSLEPRQ HFNTLDVGAS GLNTSHSPSA SSRSSHKSSH
     TAMSEPTSTP TKLMAEASTP ALPRSATLPQ ELPVPGLSQA ATMPAPLPSP SSCDLTQQLL
     PQTVLQSTPA PMAQFSAQFS MFQTIKDQLE QRTRILQANI RWQQEELHKI QEQLCLVQDS
     NVQMFLQQPA VSLSFSSTQR PEAQQQLQQR SAAVTQPQLG AGPQLPGQIS SAQVTSQHLL
     RESSVISTQG PKPMRSSQLM QSSGRSGSSL VSPFSSATAA LPPSLNLTTP ASTSQDASQC
     QPSPDFSHDR QLRLLLSQPI QPMMPGSCDA RQPSEVSRTG RQVKYAQSQT VFQNPDAHPA
     NSSSAPMPVL LMGQAVLHPS FPASQPSPLQ PAQARQQPPQ HYLQVQAPTS LHSEQQDSLL
     LSTYSQQPGT LGYPQPPPAQ PQPLRPPRRV SSLSESSGLQ QPPR
//
